Clinical trials in Maastricht – page 18

326 clinical trials in Maastricht, The Netherlands across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Maastricht at a glance

326

clinical trials

Research sites6

Quick filters

326 trials in Maastricht

Open in trial search

Peripheral arterial occlusive disease

Not recruiting

Study on Genotype-Guided Treatment with Carbasalate Calcium, Telmisartan, and Rivaroxaban for Patients with Peripheral Arterial Disease

Registered drugNo placebo

Study on Genotype-Guided Treatment with Carbasalate Calcium, Telmisartan, and Rivaroxaban for Patients with Peripheral Arterial Disease

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Carbasalate Calcium
Sponsor:Stichting Radboud University Medical Center

Contact Research Centre

Nephrotic syndrome

Not recruiting

Study of levamisole and prednisolone combination to prevent nephrotic syndrome relapse in children aged 2-16 years with first episode of steroid-sensitive disease

Investigational

Study of levamisole and prednisolone combination to prevent nephrotic syndrome relapse in children aged 2-16 years with first episode of steroid-sensitive disease

Investigational

The Netherlands

Participants:0–17 years
Substances:Levamisole Hydrochloride
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Pancreatic carcinoma metastatic

Not recruiting

Study of Irinotecan with S1 or 5-Fluorouracil for Patients with Metastatic Pancreatic Cancer After Gemcitabine Treatment

Registered drugNo placebo

Study of Irinotecan with S1 or 5-Fluorouracil for Patients with Metastatic Pancreatic Cancer After Gemcitabine Treatment

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Breast cancer metastatic

Not recruiting

Study comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer

Registered drugNo placebo

Study comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:BOOG Study Center B.V.

Contact Research Centre

Acute coronary syndrome

Not recruiting

Study Comparing Dabigatran with Ticagrelor or Clopidogrel for Patients with Acute Coronary Syndrome Undergoing PCI

Registered drugNo placebo

Study Comparing Dabigatran with Ticagrelor or Clopidogrel for Patients with Acute Coronary Syndrome Undergoing PCI

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ticagrelor
Sponsor:Zuyderland Medisch Centrum Stichting

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Study of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease

Registered drug

Study of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Patisiran
Sponsor:Alnylam Pharmaceuticals Inc.

Contact Research Centre

Colorectal cancer metastatic+1

Not recruiting

Study of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer

Registered drugNo placebo

Study of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cetuximab
Sponsor:Pfizer Inc.

Contact Research Centre

Prostate cancer

Not recruiting

Study on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment

Registered drug

Study on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Enzalutamide
Sponsor:Medivation Inc.

Contact Research Centre

Prostate cancer

Not recruiting

Study on the Effect of Adding Leuprorelin Acetate to Radiotherapy for Patients with Oligo-recurrent Prostate Cancer with Up to 4 Metastases

Registered drugNo placebo

Study on the Effect of Adding Leuprorelin Acetate to Radiotherapy for Patients with Oligo-recurrent Prostate Cancer with Up to 4 Metastases

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Leuprorelin Acetate
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Impaired gastric emptying+1

Not recruiting

Study on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis

Investigational

Study on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Naronapride Dihydrochloride Trihydrate
Sponsor:Dr. Falk Pharma GmbH

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Gilteritinib
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Myopia

Not recruiting

Comparison of Atropine 0.

Registered drugNo placebo

Comparison of Atropine 0.

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Atropine Sulfate
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Maastricht

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on colorectal cancer, breast cancer, and melanoma treatments. Studies include novel therapy combinations and personalized treatment approaches.

Advanced treatment protocols for metastatic conditions
Immunotherapy interventions
Diagnostic imaging improvements

Particular emphasis on targeted therapies and treatment optimization for various cancer types.

02 Chronic Disease Management

Research focusing on chronic kidney disease, fibromyalgia, and inflammatory bowel conditions. Studies evaluate new therapeutic approaches and treatment combinations.

Novel drug combinations
Disease progression monitoring
Quality of life improvements

Emphasis on developing effective long-term management strategies for chronic conditions.

03 Cardiovascular Studies

Investigations into peripheral arterial disease and cardiomyopathy treatments. Research includes innovative therapeutic approaches and preventive strategies.

Cardiovascular risk reduction
Treatment optimization
Disease prevention protocols

Focus on improving patient outcomes through targeted interventions and preventive measures.

Back to the Netherlands All countries